Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Obesity

The little-known oil which could be driving obesity – and is in more foods than you think

Soybean oil is commonly found in processed foods and has been linked to obesity

The Independent UK

What having a beer belly really says about your health

Excess weight, especially around the waist, leads to fatty material building up in the arteries and major organs

The Independent UK

Smartphones at age 12 linked to worse health

Preteens who own smartphones are likelier to have depression, obesity and insufficient sleep than their peers.

Axios

From analysis to the latest developments in health,
read the most diverse news in one place.

Weight-loss drug doesn’t reduce risk of Alzheimer’s – new studies

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer’s, according to two large new studies. The results close the door, for now, on hopes that a treatment for diabetes and obesity might also help protect the brain.

The Conversation

We created health guidelines for fighting loneliness - here’s what we recommend

Social isolation kills. It increases your risk of death by 30% — roughly the same as smoking cigarettes and much worse than factors such as obesity and sedentary living.

The Conversation

Has America's obesity rate plateaued?

Some recent national numbers suggest the obesity rate has plateaued or even declined. Experts are skeptical.

LiveScience

3 Weight-Loss Drug Stocks To Consider For 2026

The global weight loss drug market, perhaps ironically, is growing like gangbusters these days. Globally, it’s set to expand from $15 billion in 2024 to $150 billion by 2035, according to Morgan Stanley.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Making GLP-1 weight loss drugs cheaper isn’t enough to address America’s obesity problem – here’s why

The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with pharmaceutical giants, announced Nov. 6, 2025, will reduce the monthly prices of these medications by hundreds of dollars.

The Conversation

Once-a-day pill could offer a cheaper alternative to weight loss jabs

About 2.5million people in the UK use GLP-1 drugs for weight loss

The Independent UK

GLP-1s could end up being ‘the first true longevity drug’ as the world battles a rising obesity crisis

Top scientists from have suggested that GLP-1s could have broader effects than just tackling obesity and diabetes.

Fortune

Once-a-day pill will provide ‘more access’ to weight loss medication

It is expected that the tablet will be much cheaper than weight loss jabs.

Evening Standard

France moves to shut down rogue sites selling fake weight-loss drugs

French regulators have intensified their crackdown on the booming online trade in illicit weight-loss medicines, targeting platforms and sellers pushing unlicensed anti-obesity products.

Radio France Internationale

Ultra-processed foods fuelling global health crisis and experts urge worldwide policy reform

Experts have linked high UPF consumption to higher risk of obesity, diabetes, heart disease, depression, and early death.

Euronews

The common foods found to harm every major organ

UPFs have been linked to poor health, including an increased risk of obesity, heart disease, cancer and early death

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times

Novo Nordisk CEO's Bold Vow: Full Commitment to Weight-Loss Pill as Wegovy Price Falls

Novo Nordisk cuts Wegovy's price and commits fully to its upcoming weight-loss pill to stay competitive in the fast-growing obesity drug market.

International Business Times UK

With $199 Price, Ozempic Prescriptions Expected to Soar — Experts Warn of Risks

Novo Nordisk's new $199 offer for Ozempic and Wegovy aims to improve access for obesity and diabetes treatments, but experts warn of potential serious side effects.

The Guardian - UK

Nestlé accused of ‘risking health of babies for profit’ over added sugar in cereals sold in African countries

Campaigners say the company is contributing to rising rates of childhood obesity, while the firm says it is helping to combat malnutrition

The Independent UK

Study uncovers weight loss drug’s hidden impact on our brains

The study included three severely obese patients who struggled to control their eating habits

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Price of Wegovy and Ozempic weight loss drugs slashed with certain customers saving $150 per month

A recent poll found that about half of the people who take the treatments say it was hard to afford them

Kiplinger

Medicare to Cover Obesity Drugs Under Trump Deal for as Little as $50. What You Need to Know

Trump's deal slashes GLP-1 drug costs for Medicare beneficiaries and others, unlocking coverage for millions with obesity and related conditions.

The Guardian - UK

High blood pressure rates in children nearly doubled in 20 years, global review finds

Poor diet, inactivity and obesity believed to have caused hypertension for millions of under-19s around the world

International Business Times UK

Trump's Visa Crackdown: 'Heavy' Foreign Visitors Told They May Be Barred From The U.S.

A newly revealed State Department cable instructs visa officers to consider chronic conditions — including obesity — when refusing visas as potential 'public charge' cases; lawyers warn of bias and legal uncertainty. Facts, expert views, and what applicants must know.

Evening Standard

US could block obese visitors from entering country under new visa guidance

Obesity is just one of the conditions which could get visitors denied a US visa

The Independent UK

New Trump directive could deny more visas based on applicants' health and finances

A new directive by President Donald Trump’s administration could make it more difficult for foreigners to visit or live in the United States if they have certain medical conditions such as diabetes or obesity or lack the economic resources and assets to support themselves

Euronews

Markets exhale as Novo Nordisk withdraws from Metsera bidding war

Equity markets delivered a mixed response after Pfizer won the bidding war for anti-obesity drugmaker Metsera, as Metsera’s shares slipped but Novo Nordisk’s stock rose on news it was bowing out of the race.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.